Immunoglobulin D multiple myeloma

被引:4
作者
Benchekroun, Laila [1 ,2 ]
Ouzzif, Zohra [2 ]
Bouabdillah, Mounya [1 ,2 ]
Jaouhar, Nouzha [1 ]
Aoufir, Fatiha [1 ]
Aoufi, Farida [1 ]
Chabraoui, Layachi [1 ,2 ]
机构
[1] CHU, Cent Biochim Lab, Rabat, Sale, Morocco
[2] Fac Med & Pharm, Rabat, Morocco
关键词
multiple myeloma; D immunoglobulin; immunofixation; renal failure; IGD MYELOMA;
D O I
10.1684/abc.2011.0617
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Immunoglobulin D multiple myeloma is a rare form of multiple myeloma and affects a young population. It is characterized by its clinical severity and poor prognosis. We report four cases of multiple myeloma immunoglobulin D diagnosed and supported in the university hospital Center of Sale and Rabat-Morocco. We propose to study the epidemiological, clinical and biological characteristics of this rare type of monoclonal gammopathy. Through the observations reported, the clinical aspect of myeloma is characterized by the high frequency of extra-bone manifestations including impaired kidney function. The immunoglobulin D multiple myeloma is mainly type lambda, the IgD kappa is rare, the predominance of lambda light chains could be explained by rearrangements at the immunoglobulin genes. Bence-Jones proteinuria is almost constant in the multiple myeloma immunoglobulin D, it is mainly type lambda, reflecting excess production of light chains by plasma cells. The marrow is invaded by plasma cells in very different proportions of up to 95%. It's a clinical entity, difficult to diagnose, particularly when low homogeneous band on electrophoresis goes unnoticed for an eye inexperienced or when immune serum anti-IgD was not used during the immunotyping.
引用
收藏
页码:581 / 587
页数:7
相关论文
共 19 条
[1]  
ALCALAY M, 1975, SEM HOP PARIS, V51, P1227
[2]  
AMINE B, 2004, REV RHUM, V71, P617
[3]  
Barille-Nion Sophie, 2003, Hematology Am Soc Hematol Educ Program, P248
[4]  
BARTOLONI C, 1980, BLOOD, V56, P898
[5]  
BATAILLE R, 1992, BLOOD, V80, P733
[6]   IMMUNOGLOBULIN-D MULTIPLE-MYELOMA - PRESENTING FEATURES, RESPONSE TO THERAPY, AND SURVIVAL IN A SERIES OF 53 CASES [J].
BLADE, J ;
LUST, JA ;
KYLE, RA .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2398-2404
[7]   Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience [J].
Chong, Yong Pil ;
Kim, Shin ;
Ko, Ok Bae ;
Koo, Ja Eun ;
Lee, Danbi ;
Park, Sang Hyoung ;
Park, Soo Jung ;
Lee, Daeho ;
Kim, Sang We ;
Suh, Cheolwon .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (05) :819-824
[8]   4 CASES OF IGD MULTIPLE-MYELOMA [J].
DEAM, DR ;
BUSMANIS, IA ;
HUSSEIN, S ;
RATNAIKE, S .
PATHOLOGY, 1991, 23 (04) :339-343
[9]  
HASSIKOU H, 2007, J FR OPHTALMOL, V30, P185
[10]  
Kizaki Masahiro, 2004, Keio J Med, V53, P178